Insulin effects on glucose tolerance, hypermetabolic response, and circadianmetabolic protein expression in a rat burn and disuse model

Heather F. Pidcoke, Lisa A. Baer, Xiaowu Wu, Steven Wolf, James K. Aden, Charles E. Wade

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Insulin controls hyperglycemia after severe burns, and its use opposes the hypermetabolic response. The underlying molecular mechanisms are poorly understood, and previous research in this area has been limited because of the inadequacy of animal models to mimic the physiological effects seen in humans with burns. Using a recently published rat model that combines both burn and disuse components, we compare the effects of insulin treatment vs. vehicle on glucose tolerance, hypermetabolic response, muscle loss, and circadian-metabolic protein expression after burns. Male Sprague-Dawley rats were assigned to three groups: cage controls (n = 6); vehicle-treated burn and hindlimb unloading (VBH; n = 11), and insulin-treated burn and hindlimb unloading (IBH; n = 9). With the exception of cage controls, rats underwent a 40% total body surface area burn with hindlimb unloading, then IBH rats received 12 days of subcutaneous insulin injections (5 units•kg-1•day-1), and VBH rats received an equivalent dose of vehicle. Glucose tolerance testing was performed on day 14, after which blood and tissues were collected for analysis. Body mass loss was attenuated by insulin treatment (VBH = 265 ± 17 g vs. IBH = 283 ± 14 g, P = 0.016), and glucose clearance capacity was increased. Soleus and gastrocnemius muscle loss was decreased in the IBH group. Insulin receptor substrate-1, AKT, FOXO-1, caspase-3, and PER1 phosphorylation was altered by injury and disuse, with levels restored by insulin treatment in almost all cases. Insulin treatment after burn and during disuse attenuated the hypermetabolic response, increased glucose clearance, and normalized circadian-metabolic protein expression patterns. Therapies aimed at targeting downstream effectors may provide the beneficial effects of insulin without hypoglycemic risk.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume307
Issue number1
DOIs
StatePublished - Jul 1 2014
Externally publishedYes

Fingerprint

Insulin
Glucose
Hindlimb Suspension
Proteins
Burns
Skeletal Muscle
Therapeutics
Insulin Receptor Substrate Proteins
Body Surface Area
Subcutaneous Injections
Hypoglycemic Agents
Caspase 3
Hyperglycemia
Sprague Dawley Rats
Animal Models
Phosphorylation
Muscles
Control Groups
Wounds and Injuries
Research

Keywords

  • Burn and disuse
  • Circadian rhythm
  • Glucose tolerance
  • Hypermetabolism
  • Insulin

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Insulin effects on glucose tolerance, hypermetabolic response, and circadianmetabolic protein expression in a rat burn and disuse model. / Pidcoke, Heather F.; Baer, Lisa A.; Wu, Xiaowu; Wolf, Steven; Aden, James K.; Wade, Charles E.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 307, No. 1, 01.07.2014.

Research output: Contribution to journalArticle

@article{8d52337db58941f18a999d5fe2db7368,
title = "Insulin effects on glucose tolerance, hypermetabolic response, and circadianmetabolic protein expression in a rat burn and disuse model",
abstract = "Insulin controls hyperglycemia after severe burns, and its use opposes the hypermetabolic response. The underlying molecular mechanisms are poorly understood, and previous research in this area has been limited because of the inadequacy of animal models to mimic the physiological effects seen in humans with burns. Using a recently published rat model that combines both burn and disuse components, we compare the effects of insulin treatment vs. vehicle on glucose tolerance, hypermetabolic response, muscle loss, and circadian-metabolic protein expression after burns. Male Sprague-Dawley rats were assigned to three groups: cage controls (n = 6); vehicle-treated burn and hindlimb unloading (VBH; n = 11), and insulin-treated burn and hindlimb unloading (IBH; n = 9). With the exception of cage controls, rats underwent a 40{\%} total body surface area burn with hindlimb unloading, then IBH rats received 12 days of subcutaneous insulin injections (5 units•kg-1•day-1), and VBH rats received an equivalent dose of vehicle. Glucose tolerance testing was performed on day 14, after which blood and tissues were collected for analysis. Body mass loss was attenuated by insulin treatment (VBH = 265 ± 17 g vs. IBH = 283 ± 14 g, P = 0.016), and glucose clearance capacity was increased. Soleus and gastrocnemius muscle loss was decreased in the IBH group. Insulin receptor substrate-1, AKT, FOXO-1, caspase-3, and PER1 phosphorylation was altered by injury and disuse, with levels restored by insulin treatment in almost all cases. Insulin treatment after burn and during disuse attenuated the hypermetabolic response, increased glucose clearance, and normalized circadian-metabolic protein expression patterns. Therapies aimed at targeting downstream effectors may provide the beneficial effects of insulin without hypoglycemic risk.",
keywords = "Burn and disuse, Circadian rhythm, Glucose tolerance, Hypermetabolism, Insulin",
author = "Pidcoke, {Heather F.} and Baer, {Lisa A.} and Xiaowu Wu and Steven Wolf and Aden, {James K.} and Wade, {Charles E.}",
year = "2014",
month = "7",
day = "1",
doi = "10.1152/ajpregu.00312.2013",
language = "English (US)",
volume = "307",
journal = "American Journal of Physiology - Endocrinology and Metabolism",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "1",

}

TY - JOUR

T1 - Insulin effects on glucose tolerance, hypermetabolic response, and circadianmetabolic protein expression in a rat burn and disuse model

AU - Pidcoke, Heather F.

AU - Baer, Lisa A.

AU - Wu, Xiaowu

AU - Wolf, Steven

AU - Aden, James K.

AU - Wade, Charles E.

PY - 2014/7/1

Y1 - 2014/7/1

N2 - Insulin controls hyperglycemia after severe burns, and its use opposes the hypermetabolic response. The underlying molecular mechanisms are poorly understood, and previous research in this area has been limited because of the inadequacy of animal models to mimic the physiological effects seen in humans with burns. Using a recently published rat model that combines both burn and disuse components, we compare the effects of insulin treatment vs. vehicle on glucose tolerance, hypermetabolic response, muscle loss, and circadian-metabolic protein expression after burns. Male Sprague-Dawley rats were assigned to three groups: cage controls (n = 6); vehicle-treated burn and hindlimb unloading (VBH; n = 11), and insulin-treated burn and hindlimb unloading (IBH; n = 9). With the exception of cage controls, rats underwent a 40% total body surface area burn with hindlimb unloading, then IBH rats received 12 days of subcutaneous insulin injections (5 units•kg-1•day-1), and VBH rats received an equivalent dose of vehicle. Glucose tolerance testing was performed on day 14, after which blood and tissues were collected for analysis. Body mass loss was attenuated by insulin treatment (VBH = 265 ± 17 g vs. IBH = 283 ± 14 g, P = 0.016), and glucose clearance capacity was increased. Soleus and gastrocnemius muscle loss was decreased in the IBH group. Insulin receptor substrate-1, AKT, FOXO-1, caspase-3, and PER1 phosphorylation was altered by injury and disuse, with levels restored by insulin treatment in almost all cases. Insulin treatment after burn and during disuse attenuated the hypermetabolic response, increased glucose clearance, and normalized circadian-metabolic protein expression patterns. Therapies aimed at targeting downstream effectors may provide the beneficial effects of insulin without hypoglycemic risk.

AB - Insulin controls hyperglycemia after severe burns, and its use opposes the hypermetabolic response. The underlying molecular mechanisms are poorly understood, and previous research in this area has been limited because of the inadequacy of animal models to mimic the physiological effects seen in humans with burns. Using a recently published rat model that combines both burn and disuse components, we compare the effects of insulin treatment vs. vehicle on glucose tolerance, hypermetabolic response, muscle loss, and circadian-metabolic protein expression after burns. Male Sprague-Dawley rats were assigned to three groups: cage controls (n = 6); vehicle-treated burn and hindlimb unloading (VBH; n = 11), and insulin-treated burn and hindlimb unloading (IBH; n = 9). With the exception of cage controls, rats underwent a 40% total body surface area burn with hindlimb unloading, then IBH rats received 12 days of subcutaneous insulin injections (5 units•kg-1•day-1), and VBH rats received an equivalent dose of vehicle. Glucose tolerance testing was performed on day 14, after which blood and tissues were collected for analysis. Body mass loss was attenuated by insulin treatment (VBH = 265 ± 17 g vs. IBH = 283 ± 14 g, P = 0.016), and glucose clearance capacity was increased. Soleus and gastrocnemius muscle loss was decreased in the IBH group. Insulin receptor substrate-1, AKT, FOXO-1, caspase-3, and PER1 phosphorylation was altered by injury and disuse, with levels restored by insulin treatment in almost all cases. Insulin treatment after burn and during disuse attenuated the hypermetabolic response, increased glucose clearance, and normalized circadian-metabolic protein expression patterns. Therapies aimed at targeting downstream effectors may provide the beneficial effects of insulin without hypoglycemic risk.

KW - Burn and disuse

KW - Circadian rhythm

KW - Glucose tolerance

KW - Hypermetabolism

KW - Insulin

UR - http://www.scopus.com/inward/record.url?scp=84903625030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903625030&partnerID=8YFLogxK

U2 - 10.1152/ajpregu.00312.2013

DO - 10.1152/ajpregu.00312.2013

M3 - Article

VL - 307

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

SN - 0193-1849

IS - 1

ER -